Impact of high frequency HLA haplotypes on clinical cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.(2019).
Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia.Biol Blood Marrow Transplant.(2019).
Outcomes of allogeneic hematopoietic stem cell transplantation for ATL with HTLV-1 antibody positive donors: Allo-HCT for ATL from HTLV-1 antibody positive donors.Biol Blood Marrow Transplant.(2019).
Clinical implications of t(11;14) in patients with multiple myeloma undergoing autologous stem cell transplantation.Biol Blood Marrow Transplant.(2018).
Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04.Int J Hematol.(2016).
Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients.Int J Hematol.(2014).
Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission.Int J Hematol.(2013).
Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group.Int J Hematol.(2013).
Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation.Pharmacotherapy.(2013).